Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque

Among the vaccines have been developed thus far against SARS-CoV-2, the mRNA-based ones have demonstrated more promising results regarding both safety and efficacy. Two remarkable features of the mRNA vaccines introduced by the Pfizer/BioNTech and Moderna companies are the use of (N(1)-methyl-pseudo...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi Sohi, Alireza, Kiani, Jafar, Arefian, Ehsan, Khosrojerdi, Arezou, Fekrirad, Zahra, Ghaemi, Shokoofeh, Zim, Mohammad Kazem, Jalili, Arsalan, Bostanshirin, Nazila, Soleimani, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472963/
https://www.ncbi.nlm.nih.gov/pubmed/34579244
http://dx.doi.org/10.3390/vaccines9091007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472963/
https://www.ncbi.nlm.nih.gov/pubmed/34579244
http://dx.doi.org/10.3390/vaccines9091007

Ejemplares similares